Manus Biggs

Manus Biggs

Auto-generated profile, based on publicly available information

Manus Biggs

CÚRAM, SFI Research Centre for Medical Devices, University of Galway, Galway, Ireland

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
MFMarc A. Fernandez-Yague
Marc A. Fernandez-Yague
SASunny Akogwu Abbah
Sunny Akogwu Abbah
LMLaoise McNamara
Laoise McNamara
Dimitrios ZeugolisDimitrios Zeugolis
Dimitrios Zeugolis
Abhay PanditAbhay Pandit
Abhay Pandit
MBManus J. Biggs
Manus J. Biggs

1 October 2010 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
MBManus Jonathan Paul Biggs
Manus Jonathan Paul Biggs
RRRobert Geoff Richards
Robert Geoff Richards
MDMatthew J. Dalby
Matthew J. Dalby

1 January 2010 in Journal of Tissue Engineering
Verified
Journal Article
Open access
PDF file
LMLaura E McNamara
Laura E McNamara
RMRebecca J McMurray
Rebecca J McMurray
MBManus J P Biggs
Manus J P Biggs
FKFahsai Kantawong
Fahsai Kantawong
RORichard Oreffo
Richard Oreffo
MDMatthew J Dalby
Matthew J Dalby
Stem cells have the capacity to differentiate into various lineages, and the ability to reliably direct stem cell fate determination would have tremendous potential for basic research and clinical therapy. Nanotopography provides a useful tool for guiding differentiation, as the features are more durable than surface chemistry and can be modified in size and shape to suit the desired application. In this paper, nanotopography is examined as a means to guide differentiation, and its application is described in the context of different subsets of stem cells, with a particular focus on skeletal (mesenchymal) stem cells. To address the mechanistic basis underlying the topographical effects on stem cells, the likely contributions of indirect (biochemical signal-mediated) and direct (force-mediated) mechanotransduction are discussed. Data from proteomic research is also outlined in relation to topography-mediated fate determination, as this approach provides insight into the global molecular changes at the level of the functional effectors.

1 October 2009 in Biomaterials
Verified
Journal Article
Closed access
MBManus J.P. Biggs
Manus J.P. Biggs
RRRobert Geoff Richards
Robert Geoff Richards
NGNikolaj Gadegaard
Nikolaj Gadegaard
CWChris D.W. Wilkinson
Chris D.W. Wilkinson
RORichard Oreffo
Richard Oreffo
MDMatthew J. Dalby
Matthew J. Dalby

1 April 2015 in Advanced Drug Delivery Reviews
Verified
Journal Article
Open access
ALA.J. Lomas
A.J. Lomas
CRC.N.M. Ryan
C.N.M. Ryan
ASA. Sorushanova
A. Sorushanova
NSN. Shologu
N. Shologu
ASA.I. Sideri
A.I. Sideri
Dimitrios ZeugolisDimitrios Zeugolis
Dimitrios Zeugolis
Tendon injuries represent a significant clinical burden on healthcare systems worldwide. As the human population ages and the life expectancy increases, tendon injuries will become more prevalent, especially among young individuals with long life ahead of them. Advancements in engineering, chemistry and biology have made available an array of three-dimensional scaffold-based intervention strategies, natural or synthetic in origin. Further, functionalisation strategies, based on biophysical, biochemical and biological cues, offer control over cellular functions; localisation and sustained release of therapeutics/biologics; and the ability to positively interact with the host to promote repair and regeneration. Herein, we critically discuss current therapies and emerging technologies that aim to transform tendon treatments in the years to come.

23 September 2008 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
MBManus J. P. Biggs
Manus J. P. Biggs
RRRobert Geoff Richards
Robert Geoff Richards
NGNikolaj Gadegaard
Nikolaj Gadegaard
RMRebecca J. McMurray
Rebecca J. McMurray
SAStanley Affrossman
Stanley Affrossman
MDMathew J. Dalby
Mathew J. Dalby